D.E. Shaw & Co’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $105K | Sell |
48,932
-17,261
| -26% | -$36.9K | ﹤0.01% | 2894 |
|
2025
Q1 | $76.1K | Buy |
66,193
+13,962
| +27% | +$16.1K | ﹤0.01% | 2865 |
|
2024
Q4 | $114K | Sell |
52,231
-54,437
| -51% | -$119K | ﹤0.01% | 2795 |
|
2024
Q3 | $233K | Buy |
106,668
+17,288
| +19% | +$37.7K | ﹤0.01% | 2771 |
|
2024
Q2 | $206K | Sell |
89,380
-106,734
| -54% | -$247K | ﹤0.01% | 2821 |
|
2024
Q1 | $1.08M | Sell |
196,114
-318,505
| -62% | -$1.75M | ﹤0.01% | 2071 |
|
2023
Q4 | $1.27M | Buy |
+514,619
| New | +$1.27M | ﹤0.01% | 1946 |
|
2023
Q3 | – | Sell |
-47,112
| Closed | -$1.55M | – | 3278 |
|
2023
Q2 | $1.55M | Sell |
47,112
-24,747
| -34% | -$812K | ﹤0.01% | 1880 |
|
2023
Q1 | $2.41M | Sell |
71,859
-16,500
| -19% | -$553K | ﹤0.01% | 1756 |
|
2022
Q4 | $2.9M | Sell |
88,359
-84,371
| -49% | -$2.77M | ﹤0.01% | 1819 |
|
2022
Q3 | $6.03M | Buy |
172,730
+154,787
| +863% | +$5.4M | 0.01% | 1293 |
|
2022
Q2 | $219K | Buy |
+17,943
| New | +$219K | ﹤0.01% | 3363 |
|